Organon (OGN) Inventory Average (2021 - 2026)
Organon (OGN) posted Inventory Average of $1.4 billion for Q2 2026, down 1.98% on a QoQ basis from $1.4 billion in Q1 2026, and down 3.27% year-over-year from $1.4 billion in Q2 2025.
Analysis
Organon (OGN) Inventory Average (2021 - 2026) Analysis & Trends
Organon has reported Inventory Average for 6 years, with the latest figure at $1.4 billion in Q2 2026.
- On a quarterly basis, Inventory Average fell 3.27% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 3.27% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 3.45% from the prior year.
- Inventory Average was $1.4 billion for Q2 2026 at Organon, down from $1.4 billion in the prior quarter.
- The five-year high for Inventory Average was $1.5 billion in Q3 2025, with the low at $914.5 million in Q3 2022.
- Average Inventory Average over 5 years is $1.2 billion, with a median of $1.3 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Inventory Average jumped 32.89% in 2023, then slipped 3.27% in 2026.
- Over 5 years, Inventory Average stood at $941.0 million in 2022, then surged by 32.89% to $1.3 billion in 2023, then increased by 8.12% to $1.4 billion in 2024, then climbed by 7.03% to $1.4 billion in 2025, then retreated by 5.87% to $1.4 billion in 2026.
- The last three Inventory Average figures came in at $1.4 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 1.36 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.39 Bn |
| Dec 31, 2025 | 1.45 Bn |
| Sep 30, 2025 | 1.47 Bn |
| Jun 30, 2025 | 1.41 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Sep 30, 2024 | 1.34 Bn |
| Jun 30, 2024 | 1.28 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.06 Bn |
| Dec 31, 2022 | 941.00 Mn |
| Sep 30, 2022 | 914.50 Mn |
| Jun 30, 2022 | 948.00 Mn |
| Mar 31, 2022 | 930.50 Mn |
| Dec 31, 2021 | 916.50 Mn |
| Sep 30, 2021 | 894.50 Mn |